AbbVie

pharmaceutical company

ABBV NYSE ISIN US00287Y1091 SEC CIK 1551152 LEI FR5LCKFTG8054YNNRU85
Follow AbbVie Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $17.4B +10.3% vs same quarter last year
Net income $4.2B +2167.7% vs same quarter last year
EPS, diluted $2.37 +2270% vs same quarter last year
Operating cash flow $7.6B +8.3% vs same quarter last year
Revenue by quarter
$15.1B
$13.3B
$15.4B
$15.8B
$16.6B
$15B
$17B
$17.4B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$20B$40B$60B$80BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$61.2B$4.2B
FY24$56.3B$4.3B
FY23$54.3B$4.9B
FY22$58.1B$11.8B
FY21$56.2B$11.5B
FY20$45.8B$4.6B
FY19$33.3B$7.9B
FY18$32.8B$5.7B
FY17$28.2B$5.3B
FY16$25.6B$6B
FY15$22.9B$5.1B
FY14$20B$1.8B
FY13$18.8B$4.1B
FY12$18.4B$5.3B
FY11$17.4B$3.4B
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2570.2%24.6%6.9%
FY2470%16.2%7.6%
FY2362.4%23.5%9%
FY2270%31.2%20.4%
FY2169%31.9%20.5%
FY2066.4%24.8%10.1%
FY1977.6%39%23.7%
FY1876.4%19.5%17.4%
FY1775%33.8%18.8%
FY1677.3%36.4%23.2%
FY1580.3%33%22.5%
FY1477.8%17.1%8.9%
FY1375.6%30.1%22%
FY1275.5%31.6%28.7%
FY1173.4%20.8%19.7%
Free cash flowOperating cash flow minus capital expenditure
$0$10B$20B$30BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$17.8B
FY24$17.8B
FY23$22.1B
FY22$24.2B
FY21$22B
FY20$16.8B
FY19$12.8B
FY18$12.8B
FY17$9.4B
FY16$6.6B
FY15$7B
FY14$2.9B
FY13$5.8B
FY12$6B
FY11$5.9B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$11.7B$980M
FY24$11B$1.7B
FY23$10.5B$2B
FY22$10B$1.5B
FY21$9.3B$934M
FY20$7.7B$978M
FY19$6.4B$629M
FY18$5.6B$12B
FY17$4.1B$1.4B
FY16$3.7B$6B
FY15$3.3B$7.6B
FY14$2.7B$665M
FY13$2.6B$320M
FY12--
FY11--
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • AbbVie
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAbbVieHealthcare median
FY256.9%−30.6%
FY247.6%−47%
FY239%−58%
FY2220.4%−80.4%
FY2120.5%−71.9%
FY2010.1%−62.2%
FY1923.7%−46.3%
FY1817.4%−49.6%
FY1718.8%−45.9%
FY1623.2%−36%
FY1522.5%−38.4%
FY148.9%−35.5%
FY1322%−37.1%
FY1228.7%−29.1%
FY1119.7%−27.9%